Analytical Method Development and Validation of Thioridazine by RP-HPLC method
Clicks: 2
ID: 311274
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #28 of 34 articles by views in Journal of Clinical Advances and Research Reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Method development and validation are extremely important in the development of drug material. For many drug products, Scientists working on Investigational New Drug (IND), New Drug Application (NDA), and Abbrevated New Drug Application (ANDA) used to characterized API’S and excipients have not been sufficiently developed or validated 1,2. The objective of the present study is to establish and generate inheriting Validation data for Thioridazine RP-HPLC method.
| Reference Key |
imported_1770374304_6985c4a01c8ba
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rucha M. Chopade, Priyanka S. Patil, Nikita U. Dhake, Mohini V. Kshirsagar, Vaishnavi R. Mankar, Pranita A. Thakre, Vinayak M. Shejol |
| Journal | Journal of Clinical Advances and Research Reviews |
| Year | 2024 |
| DOI |
10.62896/jcarr.v1.i3.02
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.